UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
(Exact name of registrant as specified in its charter)
| (State or other jurisdiction of incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) |
| (Address of principal executive offices) | (Zip Code) |
(Registrant’s telephone number, including area code)
Not Applicable
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class registered |
Trading Symbol(s) |
Name of each exchange on which registered | ||
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
| Item 8.01 | Other Events. |
On May 4, 2026, CH4 Natural Solutions Corporation (the “Company”) completed its initial public offering (the “IPO”) of 20,000,000 units (the “Units”). Each Unit consists of one Class A ordinary share of the Company, par value $0.0001 per share (the “Class A Ordinary Shares”), and one-half of one warrant of the Company, each whole warrant entitling the holder thereof to purchase one Class A Ordinary Share at a price of $11.50 per share (the “Warrants”). The Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $200,000,000.
On May 4, 2026, simultaneously with the consummation of the IPO, the Company completed the private sale (the “Private Placement”) of 200,000 units (the “Private Placement Units”) at a purchase price of $10.00 per Private Placement Unit to CH4 Natural Solutions Acquisition Security Holdings, LLC generating gross proceeds to the Company of $2,000,000.
Of the net proceeds of the IPO and the sale of the Private Placement Units, a total of $200,000,000, including $6,000,000 of deferred underwriting discounts and commissions, was placed in a trust account (the “Trust Account”) with Continental Stock Transfer & Trust Company acting as trustee. An audited balance sheet of the Company as of May 4, 2026 reflecting receipt of the proceeds upon consummation of the IPO and the Private Placement has been issued by the Company and is included as Exhibit 99.1 to this Current Report on Form 8-K.
On May 6, 2026, the underwriter of the Company’s IPO exercised its over-allotment option in part and on May 8, 2026, the underwriter purchased an additional 2,000,000 Units (the “Option Units”). Each Option Unit consists of one Class A Ordinary Share and one-half of one Warrant. The Option Units were sold at a price of $10.00 per unit, generating gross proceeds to the Company of $20,000,000. Of the net proceeds of the IPO, the sale of the Private Placement Units, and the sale of the Option Units, a total of $220,000,000, including $6,600,000 of deferred underwriting discounts and commissions, was placed in the Trust Account with Continental Stock Transfer & Trust Company acting as trustee.
| Item 9.01 | Financial Statements and Exhibits. |
(d) Exhibits.
| Exhibit Number |
Description of Exhibits | |
| 99.1 | Audited Balance Sheet, as of May 4, 2026. | |
| 104 | Cover Page Interactive Data File (embedded within the Inline XBRL document). | |
1
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| CH4 NATURAL SOLUTIONS CORPORATION | ||||||
| Date: May 8, 2026 | By: | /s/ Arthuros Mangriotis | ||||
| Name: | Arthuros Mangriotis | |||||
| Title: | Chief Financial Officer, Chief Accounting Officer and Secretary | |||||
2